Results 241 to 250 of about 16,216 (335)

Effect of Device Design on the Aerosolization of a Carrier-Based Dry Powder Inhaler—a Case Study on Aerolizer® Foradile® [PDF]

, 2013
Qi Zhou, Zhenbo Tong, Patricia A. Tang, Mauro Citterio, Runyu Yang, Hak‐Kim Chan   +5 more
openalex   +1 more source

Microbubble Shell Stiffness Engineering Enhances Ultrasound Imaging, Drug Delivery, and Sonoporation

Advanced Materials, Volume 38, Issue 6, 27 January 2026.
 Shell‐engineered poly(alkyl cyanoacrylate) microbubbles with tunable stiffness improve ultrasound imaging and therapy. Adjusting the length of the alkyl chain and the glass transition temperature maintains a narrow microbubble size distribution while enhancing drug loading, sonoporation and the acoustic response.
Roman A. Barmin, MirJavad Moosavifar, Elena Rama, Julia Blöck, Anne Rix, Vladislav S. Petrovskii, Rustam A. Gumerov, Jens Köhler, Michael Pohl, Céline Bastard, Stephan Rütten, Laura Charlton, Vu Ngoc Khiêm, Fabio Domenici, Thomas Lisson, Ekaterina Savina, Rui Zhang, Jasmin Baier, Susanne Koletnik, Vasileios Koutsos, Mikhail Itskov, Gaio Paradossi, Georg Schmitz, Tina Vermonden, Laura De Laporte, Robert Göstl, Andreas Herrmann, Igor I Potemkin, Fabian Kiessling, Twan Lammers, Roger M. Pallares   +30 more
wiley   +1 more source

Microstructural Characterization of Dry Powder Inhaler Formulations Using Orthogonal Analytical Techniques. [PDF]

Pharm Res
Farias G, Ganley WJ, Price R, Conti DS, Mangal S, Bielski E, Newman B, Shur J.   +7 more
europepmc   +1 more source

Optimizing Spray-Dried Porous Particles for High Dose Delivery with a Portable Dry Powder Inhaler. [PDF]

Pharmaceutics, 2021
Son YJ, Miller DP, Weers JG.
europepmc   +1 more source

Detection of Excipient–Excipient Interaction in Dry Powder Inhaler Formulation Prepared by Spray Drying [PDF]

Aiesheh Gholizadeh‐Hashjin, Hamed Hamishehkar, Farnaz Monajjemzadeh   +2 more
openalex   +1 more source

Next‐Generation Supercapacitors: Advances in Binder‐Free Electrodes, Scalable Fabrication, and Emerging Applications

Advanced Sustainable Systems, Volume 10, Issue 1, January 2026.
Innovative fabrication methods are crucial for developing next‐generation supercapacitors. These techniques optimize electrode structures, boosting energy and power density while enabling scalable production. By overcoming current limitations, advanced fabrication unlocks supercapacitors' potential as efficient, reliable energy storage for diverse ...
Nikita A. Wadodkar, Rahul S. Salunke, Sarla K. Pawar, Ahmad Umar, Ahmed A. Ibrahim, Sheikh Akbar, Sajid Ali Ansari, Sotirios Baskoutas, Dhammanand. J. Shirale   +8 more
wiley   +1 more source

Charged Particle Dynamics in Dry Powder Inhalers

Connor Williamson, Joshua Baptiste, Melanie Hamilton, Cheng Pang, David Prime, A. J. Stace, Elena Besley   +6 more
openalex   +1 more source

Pulmonary‐Targeted Nanoparticles Interrupt the Malignant Mechanical and Biochemical Signaling Crosstalk for Idiopathic Pulmonary Fibrosis Therapy

Advanced Science, Volume 13, Issue 5, 27 January 2026.
Idiopathic pulmonary fibrosis (IPF) progression is driven by TGF‐β induced biochemical signals and mechanical signals from increased ECM stiffness. Pulmonary‐targeted VB‐RT NPs not only eliminate excessive ROS and penetrate the dense ECM collagen barrier via NO release, but also simultaneously interrupt the persistent malignant between mechanical and ...
Xue‐Na Li, Ya‐Ping Lin, Xi‐Xi Ma, Yue‐Fei Fang, Hui Wang, Chun‐Hui Cui, Chen Zhang, Jin‐You Piao, Jee‐Heon Jeong, Xian Wu Cheng, Lei Xing, Hu‐Lin Jiang   +11 more
wiley   +1 more source

Demystifying Dry Powder Inhaler Resistance with Relevance to Optimal Patient Care. [PDF]

Clin Drug Investig
Capstick TGD, Gudimetla S, Harris DS, Malone R, Usmani OS.   +4 more
europepmc   +1 more source

AZD0449, an inhaled JAK1 inhibitor, in healthy participants and patients with mild asthma

British Journal of Clinical Pharmacology, Volume 92, Issue 1, Page 257-268, January 2026.
Aims Inhaled corticosteroids (ICS) plus bronchodilator are recommended for the treatment of asthma. Targeting the JAK1‐dependent pathway may be an alternative for asthma management in patients with incomplete response to ICS. The aim of this study was to investigate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of AZD0449, a
Anna Lundahl, Rod Hughes, Joachim Almquist, David Close, Jukka Mäenpää, Ulrika Tehler, Tina Jellesmark Jensen, Szilárd Nemes, Anne‐Kristina Mercier, Zala Jevnikar, Pablo Forte Soto, Dave Singh   +11 more
wiley   +1 more source